Govt Job for Ph.D, M.Pharm as Scientist at Govt of India Enterprise

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare.

HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 7 subsidiary companies, 22 regional offices and having presence in more than 115 countries, HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.

Post : SCIENTIST E3

Job Description
1. Development of drug delivery systems/ implants for regulated markets
2. Preparation of dossier for regulatory submissions for obtaining marketing clearance in regulated markets
3. Scale up and Technology Transfer
4. Meeting audit as per regulatory requirements

Candidate Profile
Maximum Age: 40 years as on 01.07.2021
Consolidated pay range (For Fixed Term Contract engagement): 35,000 –65,000/- (Senior Manager (E3) per month.

(The consolidated pay will be fixed within the pay range depending on the qualification, experience and the current pay drawn by the candidate. The consolidated pay will be inclusive of all allowances and benefits).

Educational Qualification:
Essential: PhD in Pharmaceutics/ M.Pharm Pharmaceutics

Experience
Essential: Minimum 5 years post qualification for PhD/ Minimum 8 Years post qualification experience for M.Pharm
Desirable: Patents, Technology transfers in novel drug delivery systems

General Conditions
• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.
• Canvassing in any form will be a disqualification.

Location : Anywhere in India

Last Date : 28th July, 2021

Reference Code HLL/HR/015/2021

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation